All research papers

Cross-section measurements of lanthanum radioisotopes towards an optimized production of 133La and 135La for theranostic applications.

Targeted alpha therapy for recurrent high-grade glioma with [²²⁵Ac]-PSMA: a new theranostic approach.

Future scenarios of radioligand therapy in pheochromocytomas and paragangliomas.

“Imaging Triplets on Two Wheels”: 61Cu‑, 64Cu‑, and 68Ga-labeled Bicyclic Peptides Targeting Nectin‑4 Enable High-Contrast PET Imaging of Urothelial Carcinoma and Triple-Negative Breast Cancer

Head-to-head comparison of [¹⁸F]F-PSMA-1007 PET/CT and [⁶⁸Ga]Ga-PSMA-11 PET/CT for intraprostatic tumour detection and localisation using histopathology as reference: A prospective single-centre diagnostic accuracy study.

Immunogenic cell death as a mechanism of synergy between sunitinib and ¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy in pancreatic neuroendocrine tumors.

Post-therapy imaging of adult brain tumours: patterns, pitfalls, and practical framework.

Effects of grid size and statistical uncertainty parameters on dose calculations using the Monte Carlo algorithm in the Monaco treatment planning system for liver stereotactic body radiotherapy.

Reirradiation outcomes following salvage conventionally fractionated Gamma Knife stereotactic radiotherapy (SFGK) to recurrent primary non-glial brain tumors.

Evaluation of interfractional shift corrections in Gamma Knife radiosurgery

Commissioning and end‐to‐end validation of a combined surface‐guided and triggered kV imaging workflow for breath‐hold SBRT on a Varian TrueBeam

Feasibility of prostate offline adaptive radiation therapy using iterative reconstructed CBCT to optimize the ART workflow.

Advances in Radiotherapy for Neoadjuvant Therapy of Stage III Non-Small Cell Lung Cancer.

Predicting Response to Somatostatin Analog Therapy in GEP-NET Liver Metastases: A Machine Learning Approach with ⁶⁸Ga-DOTATATE and ¹⁸F-FDG PET/CT.

Can early ⁶⁸Ga-PSMA-11 PET/CT predict 6-month disease control in patients receiving first-line systemic therapy for metastatic clear-cell renal cell carcinoma? Protocol for the multicentre prospective phase II PSMA-RENAL study in Belgium.

Palliative Stereotactic Body Radiotherapy for Metastatic Clear Cell Sarcoma: A Case Report

Complete and durable remission in a patient with brain metastasis from gastric cancer treated with SRS followed by RC48 plus camrelizumab after progression on chemo-immunotherapy: a case report and literature review

Surgical resection with postoperative stereotactic radiosurgery versus stereotactic radiosurgery alone for large (>3 cm) multiple brain metastases: a propensity score-matched analysis

Beyond the snapshot: continuous optical surface monitoring reveals non-linear temporal dynamics and postural stability window in free-breathing breast radiotherapy

Early diagnosis of radiation-induced renal injury: from lagging indicators to multimodal, pre-fibrotic detection

Beta Atlas: Charting Global Production of Nonconventional β--Emitters for Targeted Radiopharmaceutical Therapy-Part 1.

Dosimetry with LIF:Mg,Ti (TLD-100) for locating non-paubable breast cancer using Iodine-125 seeds.

Radium-223 alters the levels of soluble immune regulators in the plasma of patients with metastatic castrate-resistant prostate cancer.

Regulatory and organisational barriers to non-commercial clinical trials in European nuclear medicine: Results from an EANM survey

Use of a novel tongue-sparing intraoral prosthesis for radiation therapy in a head and neck patient: A case report.

Clinical applications of the Halcyon O-ring linear accelerator in radiation therapy: a systematic review of treatment efficacy, workflow efficiency, and imaging integration.

Dosimetric impact of coplanar and non-coplanar arc arrangements in VMAT-based lung SABR.

Proof-of-Concept of CAIX-Targeted α-Particle Delivery in a Patient-Derived Hypoxic Head and Neck Squamous Cell Carcinoma Model.

EARL-based quantitative evaluation of administered activity reduction for [⁶⁸Ga]Ga-DOTATOC PET/CT on a 32-cm axial FOV digital BGO system: Phantom analysis and retrospective list-mode clinical assessment.

Theranostic Radiopharmaceutical-Guided Robotic Surgery for Precision Tumor Resection and Targeted Elimination of Residual Disease in Digestive System Malignancies.

Editorial: Recent advances in theranostics: endocrine tumours and beyond

New and emerging somatostatin therapies for neuroendocrine tumors: "what is in the pipeline".

Pulse width-dependent Monte Carlo source modelling for ultra-high dose rate electron beams

Circulating Cell-free DNA as a biomarker for radiation-induced injury: From mechanistic insights to clinical translation.

Ablative SABR for Pulmonary Oligometastases in the Era of Contemporary Systemic Therapies: Efficacy, Safety, and Optimal Sequencing.

AAPM Task Group 66U1 report 83.B: Quality assurance for computed‐tomography simulators in radiation oncology

Profiling proteomic responses in small intestinal neuroendocrine tumor GOT1 after [¹⁷⁷Lu]Lu-DOTATATE therapy.

Dynamics of circulating tumor cell subsets defined by PSMA and EpCAM predict survival in metastatic castration-resistant prostate cancer patients treated with 177Lu-PSMA-617

Adaptive radiation therapy for anatomical changes of the breast during whole-breast irradiation.

Minimal Target Embolization of High-Risk Component in Brain Arteriovenous Malformation Combined with Stereotactic Radiosurgery: a Proof-of-Concept Study.

EML4::RET, a novel transcript fusion in papillary thyroid cancer

Cerebral oxygen extraction fraction as an emerging imaging biomarker in mild cognitive impairment and dementia A fração de extração de oxigênio cerebral como um biomarcador de imagem emergente no comprometimento cognitivo leve e na demência

Follow-up–dependent calendar-period associations with cardiac mortality after lung cancer radiotherapy: a competing-risks SEER analysis

Quantification in bone SPECT/CT

Dose constraints for occupational and public exposure in Europe: Survey findings and insights from EURADOS WG12.

Radium-223 therapy in metastatic castration-resistant prostate cancer: baseline predictors of treatment completion and survival in a reimbursement-regulated Taiwanese cohort.

Reduced‐dose versus standard‐dose total body irradiation before allogeneic haematopoietic stem cell transplantation in adults with acute lymphoblastic leukaemia

LAFOV PET as an enabling platform for pharmacokinetics-informed digital twins

Dosimetric comparison of pipe-joint versus conventional VMAT for lattice radiotherapy in bulky tumors: a retrospective planning study.

The evolution of RTOG and NRG Oncology CNS tumors clinical trials.

Two-year outcomes following PSMA PET and MRI guided prostate SABR with simultaneous focal boost: a brief report from the ARGOS-CLIMBER phase 1/2 trial.

Clinical outcomes among patients treated with Lu-PSMA-617 and metastasis-directed EBRT for metastatic prostate cancer.

Single-time-point renal TIA estimation, sparse SPECT/CT data, and nonlinear mixed-effects modelling in [¹⁷⁷Lu]Lu-PSMA-617 therapy.

Modified Reaction Conditions for the Radiosynthesis of 11C‑Labeled Asymmetrical Guanidines and the Automated Radiosynthesis of a [11C]mIBG Analog

Patterns, causes, and clinical impact of treatment interruption on early outcomes in patients receiving radiotherapy for lung cancer: a retrospective study

Combined radioligand therapy and immunotherapy for cancer: research advances and translational challenges

Development of a Four-Module Deployable Radiological Emergency Laboratory for Rapid Internal Dosimetry and Field Assays

Structural & Thermoluminescence properties of bio−engineered ZnTiO3 nanostructures via Hoodia gordonii ethanolic extract & their dosimetric performances

Cerebral oxygen extraction fraction as an emerging imaging biomarker in mild cognitive impairment and dementia.

¹⁷⁷Lu-trastuzumab radionuclide therapy: a promising strategy for trastuzumab-resistant brain metastases in HER2+ breast cancer.